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Abstract
Objective: To describe the results of a program for the prevention of blindness caused by retinopathy of
prematurity implemented in 2002 at a tertiary-care hospital, according to screening criteria adopted in Brazil, and to
compare some aspects with the criteria adopted by other countries.
Methods:Descriptive observational study including all preterm infants born at this hospital weighing≤1,500g at
birth and/or gestational age≤32weekswho survived up to the sixthweek after birth, betweenOctober 2002and June
2006. Ophthalmic examinationswere performed from the sixthweek of life and repeated as necessary until remission
of the disease.
Results: A total of 300 newborns were included and there were 18 cases of treatable threshold disease (18/300,
6%) according to the Brazilian criteria. One patient was not treated because s/he developed the disease after hospital
discharge and did not turn up for examination in order to initiate treatment. According to the criteria suggested by
industrialized countries, the total number of exams would be reduced under the same circumstances, but 11.76% of
the cases of threshold disease would not be detected.
Conclusions: The Brazilian criteria for neonatal screening were efficient in detecting treatable cases. Blindness
was averted in 17 preterm infants in the study period. The universal use of such programat teaching hospitals or in the
public and private health networks could help prevent one of the main causes of preventable and treatable blindness
among infants in developing countries. Currently, a change in these criteria in Brazil may compromise the diagnosis of
some treatable patients.
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Introduction
Retinopathy of prematurity (ROP) is one of the major
causes of blindness among infants. It is characterized by an
epidemic pattern in several Latin American countries,
including Brazil.1,2 The incidence of blindness caused by ROP
varies across countries, and is influenced by the quality of
perinatal care and by the existence or not of screening
programs for the early diagnosis of the disease.3
This has been confirmed by reports of higher survival
rates among very low birth weight and extremely low birth
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weight preterm infants, higher pregnancy rates among
adolescents from a lower social background without proper
prenatal care in order to reduce the risks of preterm birth,
larger incidence of multiple pregnancies due to fertility
treatments, existence of more neonatal units and lack of
ophthalmic care in most neonatal units of these countries.4
Neonatal screening programs were implemented after
the1990s,whenpreliminary studiesof theMulticenter Trial of
Cryotherapy for Retinopathy of Prematurity yielded thriving
results for the treatment of ROP.5
Numerous screening criteria were established in different
countries, but it is difficult to determine which are ideal,
owing to the specific characteristics of each region. The ideal
model should contemplate examinations of all preterm
infants at risk for severe forms of the disease.3
The Brazilian guidelines for neonatal screening were
established in 2002, in the 1st Workshop on Retinopathy of
Prematurity (1stWK), organized by the International Agency
for the Prevention of Blindness, Vidi Institute, Brazilian
Council for Ophthalmology and by the Brazilian Society of
Pediatrics. After analyzing the situationofROP inBrazil, itwas
found out that preterm infants were not screened for ROP in
most cities, thus raising the prevalence of blindness or severe
visual impairment.6 In this workshop, it was difficult to
determine the number of infants visually impaired by ROP in
Brazil, since there were no guidelines for the diagnosis or
treatment on a national basis, with just some initiatives in
some public or private hospitals, which employed different
criteria for diagnosis and treatment.
Then, theneonatal screening of preterm infantswith birth
weight (BW) ≤ 1,500 g and/or gestational age (GA) ≤ 32
weeks was implemented, which included indirect binocular
ophthalmoscopy (IBO) and pupil dilation between the fourth
and sixth weeks of life at the Neonatal Intensive Care Unit
(NICU). The assessments were repeated, according to the
classificationofROPobservedorbasedon risk factors (RF) for
each patient.7
Using these criteria, a program for the prevention of
blindness due to ROP was implemented in 2002, with
systematic weekly examination of preterm infants at risk,
scheduled for neonatal screening from their birth, in addition
to an outpatient follow-up program for surviving infants up to
their first year of life.
The aim of this study is to present the results of this
program by comparing Brazilian criteria with those used in
other countries.
Methods
The study protocol was approved by the Research Ethics
Committee, and included all preterm infants born at that
hospital with BW ≤ 1,500 g or with GA ≤ 32 weeks who
survived up to the sixth week of life, when the initial
ophthalmic examination was performed, between October
2002 and June 2006. Only those preterm infants who died
before initial ophthalmic examinationwere excluded from the
study.
The clinical outcome corresponded to the onset of ROP at
any stage of development. The stages always corresponded
to the worst level of retinopathy found in any of the eyes
during patient follow-up. All patients were initially examined
at the NICU and followed up at the outpatient clinic until
vascularization of the temporal retina was completed or up to
the full stabilization of retinopathy after treatment.
There are no data about those preterm infants who died
after initial examination, after being discharged from the
NICU or about those who did not turn up for follow-up visits.
Ophthalmic examination consisted of examination of the
ocular fundus using pupil dilation (with the combined use of
0.5% tropicamide and2.5%phenylephrine eyedrops), under
IBOwith a28diopter lens (Nikon®,Melville, NY,USA) andeye
lid speculum (Alfonso Eye Speculum, Storz®, Bausch & Lomb
Inc., San Dimas, CA, USA). Scleral indentation was used
whenever necessary.
The overall incidence and the incidence by the staging of
retinopathy according to the international classification of
1984/1987 were determined.8,9
Patients with ROP 2 or 3 were submitted to weekly
examination in order to guarantee that no case of threshold
disease could go unnoticed and left untreated (threshold
disease: classically defined as the ideal time for treatment,
afterwhich the riskof anunfavorable functional outcomeorof
progression to blindness occurs in 50% of patients).7
The RF to define the periodicity of assessments were
extreme prematurity, septicemia, use of transfusions or
erythropoietin, low weight gain after birth and oxygen
therapy through mechanical ventilation or continuous
positive airway pressure (CPAP).
These criteria were compared with more selective ones,
used in industrialized countries (USA 1997/2001 and United
Kingdom 1996/2005), to determine whether the same
number of patients with threshold disease could be detected.
For treatment, an FTC 2500® 810 nm laser diode (Opto,
São Carlos, SP, Brazil) was used in a transpupillary way under
IBO, general anesthesia or sedation. Both eyes were treated
on the same occasion, after identification of threshold
disease.
Statistical analyses were carried out using SPSS (SPSS®
13.0 for Windows®, SPSS Inc., Chicago, IL, USA).
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Results
The sample included 300 preterm newborn infants (PNI).
Seventy-four patients (24.67%) had ROP. Threshold disease
affected 18 patients (6%). The staging of retinopathywith its
respective incidence rates can be seen in Table 1.
Blindness was averted in 17 preterm infants after laser
treatment when threshold disease occurred. One patient
developed threshold disease after initial examination and did
not return for follow-up visits after discharge. This patient
reached stage 5 of ROP and total bilateral blindness. Table 2
shows the characteristics and results of treatment in patients
with threshold disease.
The patients who developed threshold disease were
compared with the criteria adopted in the USA (1997/2001)
and in the United Kingdom (1996/2005). The comparison
revealed that threshold disease had not been diagnosed in
two patients, corresponding to 11.76% (Tables 3 and 4).
Discussion
Prevention of blindness in neonatal units is a recent
concept. If screening programs for retinopathy were carried
out, the number of visually impaired individuals of a
community could be remarkably reduced.10
ROPhas been themajor cause of blindness among infants
in industrialized and developing countries, due to the high
survival rate of preterm infants with lower BWand lower GA.2
The World Health Organization (WHO) estimated that of
100,000 visually impaired infants in Latin America in 2005,
24,000 cases resulted from ROP.1
This occurred due to the improvement in perinatal care
resulting from the larger number of hospitals specialized in
the treatment of risky pregnancies and from the increase in
the survival of extremely preterm infants from 8 to 35%,
approximately, in some centers, with a disease incidence
around 47% for those infants weighing between 1,000 and
1,250 g at birth.11,12 In other centers, the chance of survival
of infants with GA of 27 to 28 weeks amounted to 90% and to
95% in those with more than 32 weeks; however, these
figures vary considerably from one country to another.13
Among the improvements in prenatal care, we can cite
the preventive use of corticosteroids and prenatal assistance
in preventing preterm births. The improvement in perinatal
care after a preterm birth included the use of incubators with
controlled heat source, high-quality mechanical respirators,
high-frequency respirators, devices such as CPAP for
immediate use after birth, availability of surfactant,
erythropoietin, indomethacin, in addition to ultrasound and
x-rayequipment for thedetectionof comorbidities associated
with prematurity.14
Since 1966, WHO has used “years of blindness” as a way
to measure the extent of blindness across countries. This
factor is obtained by multiplying the number of affected
individuals by the number of estimated survival years. Thus,
it is possible to compare the prevalence rates of different
diseases and their impact on public health.15 In Brazil,
childhood blindness has shown great socioeconomic
importance when assessed by this factor, since those infants
who are born blind or visually impaired at a very early agewill
live to the ageof 70, approximately, on social securitywithout
ever having contributed to it. Moreover, blindness also affects
children’s cognitive, psychomotor and social development
throughout their lifetime.
Data from the Ministry of Health, obtained from the
1stWK, show that15,000preterm infantswereat risk forROP
in 2001. Given that 7.5% of them developed threshold
disease and that 50% would be blind if left untreated, the
approximate number of blind infants/year in Brazil amounted
to 562,with a high socioeconomic cost, since ROP is a disease
that causes severe, but treatable, visual impairment. The
number of affected infants is expected to double within the
next 20 years if preventive measures are not taken.
Ophthalmological studies have shown that neonatal
screening programs are virtually nonexistent in most
Brazilian cities, except in major capital cities and at teaching
hospitals.7,16 Therefore, nationwide neonatal screening
programs are of paramount importance.12,16
Table 1 - Incidence of retinopathy of prematurity in 300 preterm
infantswithbirthweight≤1,500gorgestational age≤32
weeks between 2002 and 2006
No. of PNI assessed (%) ROP
Without ROP 226 75.33%
With ROP 74 24.67%
ROP 1 33 11.00%
ROP 2 23 7.67%
ROP 3 16 5.33%
ROP 4 1 0.33%
ROP 5 1 0.33%
Total 300 100%
PNI = preterm newborn infant; ROP = retinopathy of prematurity.
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The program implemented at our institution also included
the introduction of knowledge on ROP in medical schools, in
residency programs in ophthalmology and neonatology and
for the nursing staff. In order to improve the program, aiming
at the efficient control of RF for the development of
retinopathy, ophthalmologists and neonatologists interacted
closely. Therefore, we have managed to qualify
ophthalmologists and technical staff for working with
preterm infants at risk for ROP, one of the aims of the 1stWK.
Another highlight of the program was the creation of a
research line involving the Departments of Ophthalmology,
Neonatology, Genetics and Nursing, with the participation of
undergraduate students, residents, graduate students and
professors.
The results of this study showed that by using the
Brazilian criteria, we could detect 18 cases of threshold
disease, with probable progression to blindness if untreated.
The 6% incidence of treatable ROP (18/300) is an important
indicator of the quality of perinatal care at the hospital, which
can be compared to the data from other hospitals, either in
Brazil or in other countries that are far more developed than
Brazil.17,18
Table 2 - Characteristics and results in 18 patients with threshold disease between 2002 and 2006
Case BW GA Sex ROP Zone GA at treatment No. of treatments Outcome
1 620 25 F ROP 3 + II 36 1 Remission
2 625 26 F ROP 3 + II 36 2 Remission
3 635 27 F ROP 3 + II 36 1 Remission
4 700 26 F ROP 3 + II 36 1 Remission
5 710 26 F ROP 3 + II 36 1 Remission
6 755 25 F ROP 3 + II 36 1 Remission
7 780 31 M ROP 3 + II 40 2 Remission
8 870 30 M ROP 3 + II 40 1 Remission
9 900 31 M ROP 3 + II 40 1 Remission
10 920 30 M ROP 3 + II 38 2 ROP 4B AO
11 935 30 M ROP 3 + II 37 1 Remission
12 990 29 M ROP 3 + II 39 1 Remission
13 1,080 26 F ROP 3 + II 37 1 Remission
14 1,230 31 M ROP 3 + II 40 1 Remission
15 1,260 28 M ROP 3 + II 37 1 Remission
16 1,315 32 M ROP 3 + II 41 1 Remission
17 1,500 30 F ROP 3 + II 40 1 Remission
18 710 29 F ROP 2 + II Not treated 0 ROP 5 AO
Mean 918.61 20.44 Mean 37.94
Median 885 29 Median 37
SD 263.40 2.33 SD 1.89
Min 620 25 Min 36
Max 1,500 32 Max 41
BW = birth weight; GA = gestational age; Max =maximum; Min =minimum; ROP = retinopathy of prematurity; SD = standard deviation.
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Based on the results of 16 programs for the diagnosis and
treatment of ROP, presented in the 1st WK, it was shown that
ROP 3, threshold disease, affected nearly 7.5% of preterm
infants with mean BW and GA of 948 g and 28.5 weeks,
respectively.17
Table 2 shows that the mean BW and GA in the group of
patients who developed threshold disease in this hospital
corresponded to 918.61 g (median 885 g; SD 263.39) and
28.44 weeks (median 29 weeks; SD 2.33). The patients with
threshold disease were treated at around 38 weeks of life
(median 37; SD 1.89). These data are also comparable to the
results obtained in other centers.18,19
The survival rate among very low birth weight preterm
infants (BW≤1,500 g orGA≤32weeks)was around 70.11%
and 33.67% among extremely low birth weight preterm
infants (BW ≤ 1,000 g or GA ≤ 28 weeks) in this hospital
during the study period.
Recently, there has been a tendency towards revising the
screening criteria initially established in several countries, in
order to make the programs economically feasible by
reducing the number of unnecessary examinations and by
maintaining the same efficacy in the detection of the
disease.20 Table 3 shows the screening criteria commonly
used in several countries.
In the USA, the American Academy of Pediatrics (AAP),
the American Academy of Ophthalmology (AAO) and the
American Association for Pediatric Ophthalmology and
Strabismus (AAPOS)21 have restricted the treatment of
infants with BW ≤ 1,500 g or GA ≤ 28 weeks or in the case of
severe clinical intercurrent events at the discretion of the
neonatologist, since 1997. In England, the Royal College of
Ophthalmologists and the British Association of Perinatal
Medicine22 have recommended the treatment of preterm
infants with BW ≤ 1,500 g or GA ≤ 31 weeks since 1996.
Had these criteria been applied to our sample, we would
have detected all 18 cases of threshold disease. This would
have been possible since there was no case of threshold
disease among infants with BW > 1,500 g or with GA > 32
weeks in our study population.
Table 3 - Screening criteria for retinopathy of prematurity in several countries and in Brazil
Country Year BW criteria GA criteria Clinical criteria
USA 1997 1,500 28 RF*
USA 2001 1,250 28 RF*
USA 2006 1,500 32 RF*
Canada 2000 1,500 30 -
United Kingdom 1996 1,500 31 -
United Kingdom 2005 1,250 30
Spain 1991-1998 1,500 33 O2 + 24 h
Spain 2001 1,250 30 -
Sweden 1993 - 32 -
Sweden 2002 - 31 -
Denmark 1990 1,750 32 -
Denmark 2004 1,500 31 -
India 2006 1,750 32 -
Brazil 2002 1,500 32 RF*
* RF: Any preterm infant with risk factors for retinopathy of prematurity. When requested by the attending neonatologist.
USA 2006: BW > 1,500 g < 2,000 g or GA > 32 weeks with unstable clinical course.
BW = birth weight; GA = gestational age; RF = risk factor.
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U.S. centers in 2001 and English centers in 2005
reassessed the criteria, showing a tendency towards
reducing the coverage of their programs, recommending the
examination of infants with BW less than 1,250 g or with
GA<30weeks (UnitedKingdom)and<28weeks (USA).23,24
If we applied these new criteria to this study, two cases of
threshold disease would not be detected (corresponding to
11.76% of those detected by the Brazilian criteria). The
number of preterm infants included in the screening program
would be reduced to 202.
In 2006, U.S. centers, after publication of the final results
of the Multicenter Trial of Cryotherapy for Retinopathy of
Prematurity and of the Early Treatment for Retinopathy of
Prematurity Randomized Trial Study,25,26 established new
guidelines for neonatal screening. All infants with
BW ≤ 1,500 g or GA ≤ 32 weeks or selected cases of infants
with BW between 1,500 and 2,000 g or GA > 32 weeks that
had important clinical intercurrent eventsmust be examined,
thus broadening the coverage of the screening programs.
Treatment may be indicated in case of pre-threshold disease
(defined by The International Classification of Retinopathy of
Prematurity Revisited27 as: disease in zone I, any stage with
plus disease; disease in zone I, stage 3 without plus disease;
or disease in zone II, stages 2 or 3, with plus disease).28
As a matter of fact, the ideal criteria for the prevention of
blindness caused by ROP depends on the particular
characteristics of each country or even of regions within the
same country. In India, in Latin American countries and in
Table 4 - Comparison of 18 patients with threshold disease according to U.S. and British screening criteria for retinopathy of
prematurity
Case BW GA
Detected
USA 1997
≤ 1,500,≤ 28
Detected
USA 2001
≤ 1,250,≤ 28
Detected
UK 1996
≤ 1,500,≤ 31
Detected
UK 2005
≤ 1,250,≤ 30
1 620 25 Yes Yes Yes Yes
2 625 26 Yes Yes Yes Yes
3 635 27 Yes Yes Yes Yes
4 700 26 Yes Yes Yes Yes
5 710 26 Yes Yes Yes Yes
6 755 25 Yes Yes Yes Yes
7 780 31 Yes Yes Yes Yes
8 870 30 Yes Yes Yes Yes
9 900 31 Yes Yes Yes Yes
10 920 30 Yes Yes Yes Yes
11 935 30 Yes Yes Yes Yes
12 990 29 Yes Yes Yes Yes
13 1.080 26 Yes Yes Yes Yes
14 1.230 31 Yes Yes Yes Yes
15 1.260 28 Yes Yes Yes Yes
16 1.315 32 Yes No Yes No
17 1.500 31 Yes No Yes No
18 710 29 Yes Yes Yes Yes
BW = birth weight; GA = gestational age.
214 Jornal de Pediatria - Vol. 83, No.3, 2007 Prevention of retinopathy of prematurity – Fortes Filho JB et al.
Eastern Europe, there is a tendency towards screening
infants with BW > 1,750 g or GA > 34 weeks, due to the fact
that ROPwasdetected in several preterm infantswith greater
BW and higher GA.3,29
In our sample, the only case of ROP 5 occurred due to the
loss of follow-up after hospital discharge.
The incidence of ROP in our study is likely to be even
higher than observed, as there are no available data on the
patients who died after the initial examination and who, for
beingmore severely ill, could have reached higher RO stages
if they had survived.
An adverse factor is that the whole group of patients
originated from the same hospital, where perinatal care
standards are applied on a routine basis to all preterm infants
at very high risk. Since this is not a population-based study
with patients from different hospitals, some of the
observations described herein should be restricted to centers
for neonatal care with similar characteristics to ours.
The Brazilian criteria fore neonatal screening after the
1st WK were efficient in detecting the cases that progressed
to threshold disease. Bilateral blindness was averted in 17
infants during the study period.
The Brazilian screening criteria for ROP should be revised
in the future in order to reduce the number of unnecessary
exams; however, at this time, changes in these criteria may
compromise the detection of treatable cases.
The program for prevention of blindness caused by
retinopathy described here, if used by other public or private
hospitals in Brazil, could reduce the national rates for
preventable infant blindness caused by prematurity.
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